Zoltán Gulyás is a senior field applications scientist for the TFF systems and filters at Repligen, providing technical support to customers in Western and Southern Europe. Gulyás has an MSc degree in ...

With the precision of monoclonal antibodies and the potency of small-molecular payloads, antibody-drug conjugates (ADC) are promising cancer therapeutics. As of this year, there are 19 ADC drugs ...

ADC Biotechnology, a Welsh company specializing in antibody-drug conjugate (ADC) contract services, said it has garnered $1.6 million (£1.14 million) in funding it will use to focus on building its ...

Dublin, April 01, 2026 (GLOBE NEWSWIRE)-- The "ADC Contract Manufacturing Market (7th Edition): Distribution by Stage of Development, Process Component, Type of Payload, Antibody Isotype, Target ...

Ribbon cutting and commissioning of a multipurpose state-of-the-art Antibody-Drug Conjugate (ADC) manufacturing facility that expands capacity by approximately 70-80% Adrian Gillespie, Chief Executive ...

The antibody-drug conjugate landscape is facing a critical inflection point. As it stands, manufacturing complexity could pose a threat to future innovation, despite the unmatched market demand. With ...

Research-backed strategy produces highly homogeneous antibody-drug conjugates (gsADCs) with consistent DAR and tumor suppression lasting over 50 days after a single dose A new white paper from ...

Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "ADC Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Stage of Development, Process Component, Target Indication, Antibody ...

DUBLIN--(BUSINESS WIRE)--The "ADC Contract Manufacturing Market (3rd Edition), 2018-2030" report has been added to ResearchAndMarkets.com's offering. The ADC Contract Manufacturing Market (3rd edition ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "ADC Contract Manufacturing Market (7th Edition): Distribution by Stage of Development, Process Component, Type of ...